GSE186280 sorafenib 1 v 0 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE186280_sorafenib_1_v_0_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE186280_sorafenib_1_v_0_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE186280_sorafenib_1_v_0_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE186280_sorafenib_1_v_0_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

non-coding RNA activated by DNA damage

Gene

multidrug resistance-related protein

Gene

HOXD antisense growth-associated long non-coding RNA

Gene

TMPO antisense RNA 1

Gene

Morf4 family associated protein 1 like 2

Gene

GABPB1 intronic transcript

Gene

NIPBL divergent transcript

Gene

ILF3 divergent transcript

Gene

zinc finger protein 37B, pseudogene

Gene

TMEM147 antisense RNA 1

  • Gene

    non-coding RNA activated by DNA damage


  • Gene

    multidrug resistance-related protein


  • Gene

    HOXD antisense growth-associated long non-coding RNA


  • Gene

    TMPO antisense RNA 1


  • Gene

    Morf4 family associated protein 1 like 2


  • Gene

    GABPB1 intronic transcript


  • Gene

    NIPBL divergent transcript


  • Gene

    ILF3 divergent transcript


  • Gene

    zinc finger protein 37B, pseudogene


  • Gene

    TMEM147 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.